• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.导致致密性骨发育不全的组织蛋白酶K前体和成熟多肽区域新突变的特征分析
J Clin Invest. 1999 Mar;103(5):731-8. doi: 10.1172/JCI653.
2
Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein.组织蛋白酶K(CTSK)的突变通过降低组织蛋白酶K蛋白水平导致致密性成骨不全症。
J Bone Miner Res. 1999 Oct;14(10):1649-53. doi: 10.1359/jbmr.1999.14.10.1649.
3
Cathepsin K gene mutations and 1q21 haplotypes in at patients with pycnodysostosis in an outbred population.远交群体中致密性成骨不全症患者组织蛋白酶K基因突变与1q21单倍型
Eur J Hum Genet. 2000 Jun;8(6):431-6. doi: 10.1038/sj.ejhg.5200481.
4
Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene.组织蛋白酶K:小鼠cDNA及基因组序列的分离与鉴定,人类致密性成骨不全症基因的同源物
Biochem Mol Med. 1996 Dec;59(2):200-6. doi: 10.1006/bmme.1996.0088.
5
Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Mutation in brief #961. Online.12例致密性骨发育不全患者中9种新型CTSK突变的分子分析与特征。简要突变#961。在线版。
Hum Mutat. 2007 May;28(5):524. doi: 10.1002/humu.9490.
6
Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.两例致密性骨发育不全患者的骨转换降低及骨结构破坏
J Clin Endocrinol Metab. 2004 Apr;89(4):1538-47. doi: 10.1210/jc.2003-031055.
7
Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease.致密性成骨不全症:组织蛋白酶K在破骨细胞功能及人类疾病中的作用与调控
Curr Mol Med. 2002 Aug;2(5):407-21. doi: 10.2174/1566524023362401.
8
Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.致密性骨发育不全症,一种由组织蛋白酶K缺乏引起的溶酶体疾病。
Science. 1996 Aug 30;273(5279):1236-8. doi: 10.1126/science.273.5279.1236.
9
Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.组织蛋白酶K的胶原酶活性取决于与硫酸软骨素的复合物形成。
J Biol Chem. 2002 Aug 9;277(32):28669-76. doi: 10.1074/jbc.M204004200. Epub 2002 May 30.
10
Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization.致密性成骨不全症患者组织蛋白酶K基因的新突变及其特征分析
J Clin Endocrinol Metab. 2000 Jan;85(1):425-31. doi: 10.1210/jcem.85.1.6247.

引用本文的文献

1
Integrated machine learning-based virtual screening and biological evaluation for identification of potential inhibitors against cathepsin K.基于集成机器学习的虚拟筛选和生物学评价以鉴定组织蛋白酶K的潜在抑制剂
Mol Divers. 2024 Apr 25. doi: 10.1007/s11030-024-10845-5.
2
Heparan sulfate selectively inhibits the collagenase activity of cathepsin K.硫酸乙酰肝素选择性抑制组织蛋白酶 K 的胶原酶活性。
Matrix Biol. 2024 May;129:15-28. doi: 10.1016/j.matbio.2024.03.005. Epub 2024 Mar 26.
3
Heparan sulfate selectively inhibits the collagenase activity of cathepsin K.硫酸乙酰肝素选择性抑制组织蛋白酶K的胶原酶活性。
bioRxiv. 2024 Jan 8:2024.01.05.574350. doi: 10.1101/2024.01.05.574350.
4
Identifying the effective combination of acupuncture and traditional Chinese medicinal herbs for postmenopausal osteoporosis therapy through studies of their molecular regulation of bone homeostasis.通过研究针灸和中药对骨稳态的分子调控作用,找出治疗绝经后骨质疏松症的有效组合。
J Tradit Chin Med. 2024 Feb;44(1):212-219. doi: 10.19852/j.cnki.jtcm.20230904.006.
5
Overlapping Phenotypes in Osteopetrosis and Pycnodysostosis in Asian-Indians.亚洲印度人中骨硬化症和致密性骨发育不全的重叠表型。
Case Rep Genet. 2021 Nov 3;2021:7133508. doi: 10.1155/2021/7133508. eCollection 2021.
6
Genetic and Molecular Evaluation: Reporting Three Novel Mutations and Creating Awareness of Pycnodysostosis Disease.遗传与分子评估:报告三个新突变并提高对先天性成骨不全症的认识。
Genes (Basel). 2021 Sep 29;12(10):1552. doi: 10.3390/genes12101552.
7
Control of Bone Matrix Properties by Osteocytes.成骨细胞对骨基质特性的控制。
Front Endocrinol (Lausanne). 2021 Jan 18;11:578477. doi: 10.3389/fendo.2020.578477. eCollection 2020.
8
Cathepsin K: The Action in and Beyond Bone.组织蛋白酶K:在骨骼内外的作用
Front Cell Dev Biol. 2020 Jun 4;8:433. doi: 10.3389/fcell.2020.00433. eCollection 2020.
9
Whole-exome sequencing identified a novel variant in an Iranian patient affected by pycnodysostosis.全外显子测序在一名患有先天性骨发育不全症的伊朗患者中鉴定出一个新的变异。
Mol Genet Genomic Med. 2020 Mar;8(3):e1118. doi: 10.1002/mgg3.1118. Epub 2020 Jan 15.
10
Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression.组织蛋白酶 K 缺乏的破骨细胞可预防哺乳期骨丢失和甲状旁腺激素抑制。
J Clin Invest. 2019 May 21;129(8):3058-3071. doi: 10.1172/JCI122936.

本文引用的文献

1
[Pyknodysostosis].[致密性骨发育不全]
Presse Med (1893). 1962 Apr 25;70:999-1002.
2
Osteopetrosis acro-osteolytica. A syndrome of osteopetrosis, acro-osteolysis and open sutures of the skull.肢端骨质溶解型骨硬化症。一种骨硬化症、肢端骨质溶解和颅骨缝线开放的综合征。
Acta Chir Scand. 1962 Dec;124:496-507.
3
Histone-like TAFs within the PCAF histone acetylase complex.PCAF组蛋白乙酰化酶复合物中的类组蛋白TAF
Cell. 1998 Jul 10;94(1):35-44. doi: 10.1016/s0092-8674(00)81219-2.
4
A strategy for rapid, high-confidence protein identification.一种用于快速、高可信度蛋白质鉴定的策略。
Anal Chem. 1997 Oct 1;69(19):3995-4001. doi: 10.1021/ac970488v.
5
Collagenase: a key enzyme in collagen turnover.胶原酶:胶原蛋白周转中的关键酶。
Biochem Cell Biol. 1996;74(6):759-75. doi: 10.1139/o96-083.
6
Autocatalytic activation of human cathepsin K.
J Biol Chem. 1997 May 23;272(21):13955-60. doi: 10.1074/jbc.272.21.13955.
7
Structure and chromosomal assignment of the human cathepsin K gene.人类组织蛋白酶K基因的结构与染色体定位
Genomics. 1997 Apr 15;41(2):258-62. doi: 10.1006/geno.1997.4631.
8
Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex.人组织蛋白酶K在毕赤酵母中的表达及抑制剂复合物的初步晶体学研究
Protein Sci. 1997 Apr;6(4):919-21. doi: 10.1002/pro.5560060421.
9
Crystal structure of human cathepsin K complexed with a potent inhibitor.与一种强效抑制剂复合的人组织蛋白酶K的晶体结构。
Nat Struct Biol. 1997 Feb;4(2):105-9. doi: 10.1038/nsb0297-105.
10
Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene.组织蛋白酶K:小鼠cDNA及基因组序列的分离与鉴定,人类致密性成骨不全症基因的同源物
Biochem Mol Med. 1996 Dec;59(2):200-6. doi: 10.1006/bmme.1996.0088.

导致致密性骨发育不全的组织蛋白酶K前体和成熟多肽区域新突变的特征分析

Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

作者信息

Hou W S, Brömme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda C S, Fraga C, Greig F, Carey J, Rimoin D L, Desnick R J, Gelb B D

机构信息

Department of Human Genetics, Mount Sinai School of Medicine, New York 10029, USA.

出版信息

J Clin Invest. 1999 Mar;103(5):731-8. doi: 10.1172/JCI653.

DOI:10.1172/JCI653
PMID:10074491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC408114/
Abstract

Cathepsin K, a lysosomal cysteine protease critical for bone remodeling by osteoclasts, was recently identified as the deficient enzyme causing pycnodysostosis, an autosomal recessive osteosclerotic skeletal dysplasia. To investigate the nature of molecular lesions causing this disease, mutations in the cathepsin K gene from eight families were determined, identifying seven novel mutations (K52X, G79E, Q190X, Y212C, A277E, A277V, and R312G). Expression of the first pro region missense mutation in a cysteine protease, G79E, in Pichia pastoris resulted in an unstable precursor protein, consistent with misfolding of the proenzyme. Expression of five mature region missense defects revealed that G146R, A277E, A277V, and R312G precursors were unstable, and no mature proteins or protease activity were detected. The Y212C precursor was activated to its mature form in a manner similar to that of the wild-type cathepsin K. The mature Y212C enzyme retained its dipeptide substrate specificity and gelatinolytic activity, but it had markedly decreased activity toward type I collagen and a cathepsin K-specific tripeptide substrate, indicating that it was unable to bind collagen triple helix. These studies demonstrated the molecular heterogeneity of mutations causing pycnodysostosis, indicated that pro region conformation directs proper folding of the proenzyme, and suggested that the cathepsin K active site contains a critical collagen-binding domain.

摘要

组织蛋白酶K是一种溶酶体半胱氨酸蛋白酶,对破骨细胞进行骨重塑至关重要,最近被确定为导致致密性成骨不全症的缺陷酶,这是一种常染色体隐性遗传性骨硬化性骨骼发育不良疾病。为了研究导致该疾病的分子损伤的性质,确定了来自8个家族的组织蛋白酶K基因中的突变,鉴定出7种新突变(K52X、G79E、Q190X、Y212C、A277E、A277V和R312G)。在毕赤酵母中表达半胱氨酸蛋白酶中的第一个前区错义突变G79E,导致前体蛋白不稳定,这与酶原的错误折叠一致。5种成熟区错义缺陷的表达显示,G146R、A277E、A277V和R312G前体不稳定,未检测到成熟蛋白或蛋白酶活性。Y212C前体以与野生型组织蛋白酶K相似的方式被激活为成熟形式。成熟的Y212C酶保留了其二肽底物特异性和明胶分解活性,但对I型胶原和组织蛋白酶K特异性三肽底物的活性明显降低,表明它无法结合胶原三螺旋。这些研究证明了导致致密性成骨不全症的突变的分子异质性,表明前区构象指导酶原的正确折叠,并提示组织蛋白酶K活性位点包含一个关键的胶原结合结构域。